Search Market Research Report
Absorbable Heart Stent Market Size, Share Global Analysis Report, 2020–2026
Absorbable Heart Stent Market by Material (Metal, and Polymer), By Application (Coronary Artery Disease, and Peripheral Artery Disease), By End-Use (Hospital & Clinics, Research and Academic Institutes, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecast 2020–2026
Industry Insights
[180+ Pages Report] Global absorbable heart stent market grow from USD 295 million in 2019 to hit USD 645 million by 2026 and is increases at a CAGR of 11.8% through 2026.
This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the absorbable heart stent industry. The report analyzes and declares the historical and current trends analysis of the absorbable heart stent industry and subsequently recommends the projected trends anticipated to be observed in the absorbable heart stent market during the upcoming years.
The absorbable heart stent market report analyzes and notifies the industry statistics at the global as well as regional and country levels in order to acquire a thorough perspective of the entireAbsorbable Heart Stent market. The historical and past insights are provided for FY 2016 to FY 2019 whereas projected trends are delivered for FY 2020 to FY 2026. The quantitative and numerical data is represented in terms of value (USD Million) from FY 2016 – 2026.
Key Insights from Primary Research
- A significant prevalence of cardiovascular disease due to various risk factors for the development of heart disease are incidences of obesity, changing habits, increasing, and addiction to alcohol is propelling the demand for absorbable heart stent market in recent years.
- The demand for the absorbable heart stent market was projected at around USD 295 million in 2019, and by the end of 2026, existing and expected developments would hit estimations of around USD 645 million.
- The “coronary artery disease” category, on the basis of application segmentation, has accounted for more than 50.0% share, in 2019.
- The “hospital & clinics” category, on the basis of application segmentation, has accounted for the largest market share in 2019.
Key Recommendations from Analysts
- North America is expected to grow at a steady rate during the forecast period owing to the increasing prevalence of a number of patients with chronic diseases and government measures towards healthcare reforms.
- The global absorbable heart stent market in the Asia-Pacific market is growing due to the rise in healthcare infrastructure growth.
- Our analysts have identified “hospital & clinics”, and “Coronary Artery Disease” categories as the leading investment pockets for the worldwide absorbable heart stent market in terms of the end-use and application segmentation respectively.
Global Absorbable Heart Stent Market Revenue Share – By Application
The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the absorbable heart stent industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.
Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the absorbable heart stent industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the Absorbable Heart Stent market.
The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the absorbable heart stent market. The absorbable heart stent market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.
The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the absorbable heart stent sector. Key strategic developments in the absorbable heart stent market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the absorbable heart stent market are appropriately highlighted in the report.
The global demand for absorbable heart stents is being driven by a rise in the geriatric population. The main risk factors for the development of cardiovascular diseases in the geriatric population are hypertension, diabetes, obesity, lack of physical inactivity, cigarette smoking, and family history. The world's geriatric population is projected to rise from 524 million in 2010 to 1.5 billion by 2050, according to the World Health Organization (WHO). This is expected to drive demand for absorbable heart stents, generating enormous opportunities for growth during the forecast period for players operating in the global market for absorbable heart stents. As per the American Heart Association, there are one or more forms of CVDs in 85.6 million adults in the U.S., of which 43.7 million adults are aged 60 years or older. Thereby, certain factors are contributing to the worldwide market.
The absorbable heart stent market research report delivers an acutevaluationand taxonomy of the absorbable heart stent industry by practically splitting the market on the basis of different types, applications, industry verticals, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the absorbable heart stent industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. Further, country-wise data for the absorbable heart stentindustry are provided for the leading economies of the world.
The absorbable heart stent market is segmented based on type, application, and region. On the basis of material segmentation, the market is classified into metal and polymer. In terms of application segmentation, the market is bifurcated into coronary artery disease and peripheral artery disease. Based on end-use, the market has been segmented into hospitals & clinics, research and academic institutes, and others.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 295 million |
Projected Market Size in 2026 |
USD 645 million |
Growth Rate |
CAGR 11.8% |
Base Year |
2019 |
Forecast Years |
2020–2026 |
Key Market Players |
Abbott Laboratories, Biotronik, Boston Scientific Corporation, Elixir Medical Corporation, Medinol Ltd, Medtronic, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, REVA Medical, Inc., STENTYS SA, and Terumo Medical Corporation, among others. |
Key Segment |
By Material, By Application, By End-Use, and By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the essential players operating in the Absorbable Heart Stent market, but not restricted to include
- Abbott Laboratories
- Biotronik
- Boston Scientific Corporation
- Elixir Medical Corporation
- Medinol Ltd
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- REVA Medical Inc.
- STENTYS SA
- Terumo Medical Corporation
- among others.
The taxonomy of the Absorbable Heart Stent Market by its scope and segmentation is as follows:
Material Analysis
- Metal
- Polymer
Application Analysis
- Coronary Artery Disease
- Peripheral Artery Disease
End-Use Analysis
- Hospital & Clinics
- Research and Academic Institutes
- Others
Regional Segmentation Analysis
- North America
- The U.S.
- Canada
- Europe
- Germany
- The UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table of Content
Industry Major Market Players
- Abbott Laboratories
- Biotronik
- Boston Scientific Corporation
- Elixir Medical Corporation
- Medinol Ltd
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- REVA Medical Inc.
- STENTYS SA
- Terumo Medical Corporation
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors